Production of the Sputnik V vaccine against coronavirus will begin in India this summer, the Russian Direct Investment Fund (RDIF) and pharmaceutical company Panacea Biotec announced on Monday.

Sputnik V was registered in India under the emergency use authorisation procedure on April 12 and vaccination against coronavirus with the Russian vaccine started on May 14. As announced in April, RDIF and Panacea have agreed to produce 100 million doses per year of Sputnik V.